5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats

被引:24
作者
Millan, MJ [1 ]
Girardon, S [1 ]
Dekeyne, A [1 ]
机构
[1] Inst Rech Servier, Dept Psychopharmacol, F-78290 Paris, France
关键词
serotonin; discriminative stimulus; 5-HT2C; drug discrimination;
D O I
10.1007/s002130050910
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rats were trained on a fixed ratio 10, food-reinforced schedule to recognize a discriminative stimulus (DS) elicited by the selective serotonin (5-HT) reuptake inhibitor (SSRI), citalopram (2.5 mg/kg, IP). The preferential, high efficacy agonist at 5-HT2C receptors, Ro60-0175, dose-dependently generalized to citalopram with an ED50 of 0.3 mg/kg, IP. Further, the selective 5-HT2C receptor antagonist, SB242,084, dose-dependently (ED50=0.1 mg/kg, IP) blocked the citalopram DS. These data suggest that 5-HT2C receptors are involved in the DS properties of the SSRI, citalopram, in rats. They do not, however, exclude a potential role of other 5-HT receptor types.
引用
收藏
页码:432 / 434
页数:3
相关论文
共 17 条
[1]   5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED [J].
BAXTER, G ;
KENNETT, G ;
BLANEY, F ;
BLACKBURN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :105-110
[2]   COMPARISON OF STIMULUS PROPERTIES OF FLUOXETINE AND 5-HT RECEPTOR AGONISTS IN A CONDITIONED TASTE-AVERSION PROCEDURE [J].
BERENDSEN, HHG ;
BROEKKAMP, CLE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (1-2) :83-89
[3]   Novel agonists of 5HT(2C) receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder [J].
Bos, M ;
Jenck, F ;
Martin, JR ;
Moreau, JL ;
Sleight, AJ ;
Wichmann, J ;
Widmer, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (17) :2762-2769
[4]  
DEAKIN JFW, 1994, IN PRESS BRIT ASS PS, V13, P87
[5]  
DEKEYNE A, 1999, IN PRESS NEUROPHARMA
[6]   Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system [J].
Duxon, MS ;
Flanigan, TP ;
Reavley, AC ;
Baxter, GS ;
Blackburn, TP ;
Fone, KCF .
NEUROSCIENCE, 1997, 76 (02) :323-329
[7]  
FORSTER EA, 1995, BRIT J PHARMACOL, V116, pP216
[8]  
Frazer A, 1997, J CLIN PSYCHIAT, V58, P9
[9]  
GLENNON RA, 1988, PSYCHOPHARMACOLOGY, V4, P16
[10]   SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist [J].
Kennett, GA ;
Wood, MD ;
Bright, F ;
Trail, B ;
Riley, G ;
Holland, V ;
Avenell, KY ;
Stean, T ;
Upton, N ;
Bromidge, S ;
Forbes, IT ;
Brown, AM ;
Middlemiss, DN ;
Blackburn, TP .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :609-620